Influence of food on the disposition of the monoamine oxidase‐A inhibitor brofaromine in healthy volunteers
- 1 April 1993
- journal article
- clinical trial
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 14 (3) , 209-215
- https://doi.org/10.1002/bdd.2510140304
Abstract
The effect of food on the bioavailability of brofaromine hydrochloride was investigated in a randomized cross‐over study. Eight healthy male volunteers were given single peroral doses of 75 mg brofaromine hydrochloride after overnight fasting or a fat‐ and proteinrich breakfast. Mean (± SD) areas under the plasma concentration‐time curves (AUC) were 9.66 (2.35) μmoll−1 h when given to the fasted volunteers and 11.82 (3.78) μmoll−1 h (p = 0.0413) when given after a substantial breakfast. Mean (± SD) maximum plasma concentrations (Cmax) were 0.71 (0.13) μmoll−1 when given to the fasted volunteers and 0.85 (0.22) μmoll−1 (p > 0.05) when given after breakfast. Thus, both the average AUC and Cmax were increased by approximately 20 per cent when brofaromine hydrochloride was given with food. The times when Cmax was reached (tmax) as well as the elimination half‐lives were not influenced by concomitant intake of food. The tolerability was the same whether brofaromine was given before or after food in healthy volunteers. The slight effect of food on the bioavailability of brofaromine should be of little therapeutic consequence because of the observed wide inter‐subject variability of the plasma levels.Keywords
This publication has 9 references indexed in Scilit:
- Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteersClinical Pharmacology & Therapeutics, 1989
- Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Brofaremine hydrochlorideDrugs of the Future, 1985
- Bayesian Approach to Bioequivalence Assessment: An ExampleJournal of Pharmaceutical Sciences, 1983
- Characterization of a New, Short-Acting and Specific Inhibitor of Type A Monoamine OxidasePublished by S. Karger AG ,1982
- Comparison of Different Methods for Decision-Making in Bioequivalence AssessmentBiometrics, 1981
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945